Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 3, 2001
[Immediate revascularization by angioplasty and coronary stents in patients over age 80 with myocardial infarction]C Loubeyre, R K Premchand, T Lefèvre, et al.
Science Advances|May 11, 2022
Molecular architecture of the human caveolin-1 complexJason C Porta, Bing Han, Alican Gulsevin, et al.
Scientific Reports|July 15, 2021
A system biology approach based on metabolic biomarkers and protein-protein interactions for identifying pathways underlying schizophrenia and bipolar disorderMd Altaf-Ul-Amin, Kazuhisa Hirose, João V Nani, et al.
Science Advances|December 3, 2020
Structure and assembly of CAV1 8S complexes revealed by single particle electron microscopyBing Han, Jason C Porta, Jessica L Hanks, et al.
World Journal of Urology|August 5, 2016
Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithmsC Rothermundt, J von Rappard, T Eisen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)M E Gore, J Bellmunt, T Eisen, et al.
ESMO Open|January 18, 2021
First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among expertsS Aeppli, M Schmaus, T Eisen, et al.
Nature Communications|March 17, 2017
A human antibody against Zika virus crosslinks the E protein to prevent infectionS Saif Hasan, Andrew Miller, Gopal Sapparapu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2012
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 studyE Calvo, B Escudier, R J Motzer, et al.
International Journal of Pharmaceutics|October 1, 2023
Evaluation of tumor growth remission in a murine model for subcutaneous solid tumors - Benefits of associating the antitumor agent crotamine with mesoporous nanosilica particles to achieve improved dosing frequency and efficacyWilliam Yoshio Oyadomari, Gabriel Lessa Anthero, Marcos R de A Silva, et al.
Pageof 19